Research Reports Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Research Reports

Drug Discovery
Research & Development
Tumor Markers

January 28, 2021

Existing drug offers targeted treatment for aggressive breast cancer

A new study claims palbociclib, an approved breast cancer drug, can treat an aggressive form of the cancer, bringing hope to thousands of afflicted women in the UK.

Continue

Existing drug offers targeted treatment for aggressive breast cancer

December 3, 2010

European conference participants agree to improve neurological diseases research

News
Research Reports

Drug Discovery

Research & Development

FDA approves Eli Lilly’s Jaypirca in relapsed or refractory CLL/SLL

AGC Biologics to expand cell line development with ATUM partnership

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Existing drug offers targeted treatment for aggressive breast cancer

European conference participants agree to improve neurological diseases research